| Composition: | Dapagliflozin 10mg + Metformin 500mg ER |
| Packaging: | 10x15 |
Dapagliflozin ▷ The first & only SGLT21 with FDA approvals across the heart failure risk continuum ▷ Provides additional clinical benefits including body weight loss and BP reduction Metformin ▷ Reduces the hepatic glucose uptake by 19% ▷ Reduces risk on micro macro vascular diabetic complications ▷ Effective in both early and late stages of T2DM ▷ Reduces blood glycemic fluctuations without an increase in hypoglycemic episodes in patients newly diagnosed with T2DM ▷ Significantly more effective as compared to sitagliptin in improving cardiometabolic risk factors